HEALTH OF WOMAN. 2016.1(107):132–136; doi 10.15574/HW.2016.107.132 
 

Bacterial vaginosis – compliant therapy with the combined preparations 
 

Vdovychenko Yu. P., Gopchuk E. N.

National Medical Academy of Postgraduate Education P. L. Shupyk, Kiev 
 

Purpose of the study: provide data on the results of studies on the use of a combination of ciprofloxacin-tinidazole in the treatment of non-specific inflammation of the genitals. 
 

Materials of and methods: the use of combined antibacterial drug Ciprolet A in the complex treatment of bacterial vaginosis. 
 

Results: analysis of the results shows the association role of microorganisms in causing bacterial vaginosis and nonspecific vaginitis; the study demonstrated the impact of the proposed method to achieve a sustained therapeutic effect. 
 

Conclusions: Ciprolet A can be recommended for therapy in the treatment of combined infectious and inflammatory conditions of the genitals. 
 

Key words: bacterial vaginosis, ciprofloxacin, tinidazol, Ciprolet A. 
 

REFERENCES

1. Bairakova GR, Prylepskaya VN. 2004. Modern principles of treatment and diagnosis bakteryalnyh vahynozov. Vestn. Rus. Assots. akusherov˗hynekolohov. 4:102˗104.

2. Bukharin OV, Konstantinova OD, Kremleva EA, Cherkasov SV. 2007. Characteristics of vaginal mykroflory at vnutrymatochnoy kontratseptsyy. J. mykrob., epydem. and immune. 4:63˗65.

3. Valyshev AV, Elagin NN, Bukharin OV. 2001. Anaerobic mykroflora zhenskoho reproductive tract. J. Microbiology 4:78˗84.

4. Gerasimov GI, Titov LP, Korshikov RL, Safyna MR. 1998. Bakteryalnyi vaginosis. Ukrainian Medical Journal 3(5):107˗112.

5. Infections, sexually transmitted diseases. 2003. Clinical protocol approved by Order of the Ministry of Health of Ukraine:582.

6. Kira EF, Berlev IV, Molchanov AL. 1999. Features techenyya pregnancy, childbirth and poslerodovoho period in women with dysbiotic abuse vagina. Journal of Obstetrics and zhenskyh diseases 2(47):8˗11.

7. Kira EF, Kocherovets VI, Pospelov VV, Hanyna GI. 1994. Application eubiotics of treatment for bacterial vaginosis. Antibiotics and hymyoterapy 2-3(39):31˗35.

8. Konstantinova OD, Kremleva EA, Cherkasov SV, Chertkov KL. 2000. Mykroflora reproductive tract when women vnutrymatochnyh interventions. J. mykrob., epydem. and immune 2:98˗100.

9. Korshunov VM, Hudyeva ZA, Efymov BA et al. 1999. Study byfydoflory vagina in women of reproductive age. J. mykrob., еpydem. and immune. 4:74˗78.

10. Mazankov LN, Shevelev SA, Lykov EA. 2011. Probiotics for sovremennom stages – clinical approaches and field application. Posobye for doctors:40.

11. Nikonov AN, Astsaturova ER. 1999. Treatment of bacterial vaginosis in beremennyh. Obstetrics and Gynaecology 4:41˗43.

12. US Patent number 5,645,830 A, A 61 K 35/20. – (22) 09/19/94 (40) 07/08/97. Molochnokyslye bacteria semeystva Lactobacillaceae, Methods and sostavy, soderzhaschye dry milk and obezzhyrennoe These bacteria for Prevention mochepolovyh ​​bakteryalnyh ynfektsyonnyh diseases.

13. Podolyaka DV, Tumasov AP. 2000. Treatment of bacterial vaginosis in beremennyh. Infectious control. 1˗2:14˗15.

14. Semenov TB, Vorobev AA, Ang A et al. 2005. Characterization of microbiota of patients with nonspecific purulent-vospalytelnymy process. Proc. Proceedings. 190.

15. Tyutyunnik VL. 2005. Pathogenesis, diagnosis and methods of treatment bacterial vaginosis. Pharmatech. 2(98):20˗24.

16. Elmer GW, Surawicz CM, McFarland LV. 2013. Biotherapeutic agents. JAMA 275:870˗6.

17. Mehta A, Talwalkar J, Shetty CV et al. 2012. Microbial flora of the vagina. Microecology and therapy 23:1˗7.

18. McGregor JA, French JI, Seo R. 1993. Premature of membranes and bacterial vaginosis. Amer. J. Obstet. Gyn. 169(2):463˗466.

19. Pennenoat G, Yoly˗Guillou ML et all. 2002. Treatment of genital infections in gynecology. Obstet Fertil. 30:744˗746.

20. Thomason JL, Gelbard SM, Scaglione NJ. 2001. Bacterial vaginosis: current rewiew with indications for asymptomatic therapy. Amer J Obstet Gynecol. 165(4):1210˗1217.